CASE #5 Flashcards

1
Q

A 52 years old female patient presents to your office with chief complaint of irregular periods. When asked for details she also complains of hot flashes and irritability. A blood test confirms a diagnosis of perimenopause. She then expresses her interest in HRT. You warned the patient about the side effects of estrogen therapy. Which of the following side effects is least likely to be associated with estrogen therapy?

A. Increase the risk of thrombosis
B. Increase HDL
C. Increase LDL
D. Increase endometrial growth
E. Increase water retention
A

Increase LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
Growth hormone (GH), also known as somatotropin , is a peptide hormone that stimulates growth, cell reproduction and regeneration. An investigational drug, BIN1029, tested in preclinical trial was found to act on the hypothalamus and pituitary gland to inhibit the release of GH by feedback mechanism.
Question 1: Which of the following endogenous molecules has the same mechanism of action?
A. Ghrelin
B. Insulin-like growth factor-1
C. Growth hormone–releasing hormone
D. Somatostatin
E. Adenocorticotropic hormone
A

Insulin-like growth factor-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Question 2: Which of the following pituitary gland-acting drugs would be effective in the treatment of acromegaly?

A. Urofollitropin
B. Menotropin
C. Pegvisomant
D. Cosyntropin
E. Leuprolide
A

Pegvisomant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Insulin is a hormone produced by beta cells in the pancreas. Its primary function is to lower blood glucose. The release of insulin is controlled by blood glucose levels and several hormones including glucagon, GH, glucocorticoids and thyroid hormone. Which of the following statements is least accurate description of the biological functions of insulin?
A. Promotes the formation of storage forms of energy and suppress their catabolism
B. Promotes glucose uptake into cells and its conversion to glycogen
C. Promotes gluconeogenesis
D. Stimulates the transport of amino acids and subsequent protein synthesis
E. Increases the production of body fat

A

Promotes gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A 37-year-old male presents with fatigue, nausea, vomiting, weight loss, malaise and dizziness. On examination, marked skin and buccal hyperpigmentation and orthostatic hypotension were diagnosed. He has no relevant family history. Baseline biochemistry is highly suggestive of Addison’s disease. Which of the following sets of laboratory results would confirm a diagnosis of Addison’s disease in this patient?

A. Low cortisol, low adenocorticotropic hormone (ACTH)
B. High cortisol, low adenocorticotropic hormone (ACTH)
C. Low cortisol, high adenocorticotropic hormone (ACTH)
D. High cortisol, high adenocorticotropic hormone (ACTH)
E. The results do not relate to the conditions described

A

Low cortisol, high adenocorticotropic hormone (ACTH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A 57-year-old male was referred for evaluation of polyuria which he had been experiencing for at least one year. His brother had a history of polyuria, but less intense. Polyuria in adults is defined as urine output more than 3L/day (>40ml/kg/day). He is also experiencing excessive thirst. His medical history is unremarkable except for hyperlipidemia, for which he takes atorvastatin. He was diagnosed with Diabetes Insipidus following blood electrolyte test and urinalysis. Which of the following drugs would be recommended in this patient?

A. Pergolide
B. Desmopressin
C. Hydrocortisone
D. Cosyntropin
E. Follitropin
A

Desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A 68-year-old retired lawyer initially complained of frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past months, he has reported a few episodes of hematuria and incontinence. In addition to his urologic symptoms, the patient complained of low-grade, constant back pain and bouts of constipation. A digital rectal examination revealed enlarged prostate gland with several palpably discreet nodules. His prostate-specific antigen (PSA) level is 25ng/mL (range: 0.0–4.0 ng/mL) up from 12ng/mL six months ago. Histologic evaluation of the biopsy specimens revealed adenocarcinoma representing 55% of biopsied material (figure below) confirming a diagnosis of prostate cancer. An antagonist of androgen receptor was prescribed. Which of the following drugs has been prescribed?

A. Mestranol
B. Donazol
C. Norgestrel
D. Clomiphene
E. Flutamide
A

Flutamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Progestins are a group of naturally occurring or synthetic steroid hormones. The naturally occurring progestin is progesterone. Progesterone is produced in response to LH and has numerous biological functions including the inhibition of the formation of gonadotropins. Which of following indications is least likely to be associated with progestins therapy?

A. Contraception
B. Dysfunctional Uterine Bleeding
C. Dysmenorrhea
D. Endometriosis
E. Acne
A

Acne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Leuprolide is a synthetic analogue of gonadotropin-releasing hormone (GnRH) used to treat breast cancer and prostate cancer. Which of the following statements describes best the mechanism of leuprolide?

A. Stimulate GnRH receptors in a pulsatile fashion causing downregulation of receptors resulting in impaired release of FSH and LH
B. Stimulate GnRH receptors in a non-pulsatile fashion causing upregulation of receptors resulting in impaired release of FSH and LH
C. Stimulate GnRH receptors in a non-pulsatile fashion causing downregulation of receptors resulting in impaired release of FSH and LH
D. Stimulate GnRH receptors in a pulsatile fashion causing downregulation of receptors resulting in increased release of FSH and LH
E. Stimulate the LHRH receptor in a non-pulsatile fashion causing downregulation of receptors resulting in increased release of FSH and LH

A

Stimulate GnRH receptors in a non-pulsatile fashion causing downregulation of receptors resulting in impaired release of FSH and LH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A 65 years old female patient with history of hypertension and edema is receiving treatment for rheumatoid arthritis affecting both knees.

Question 1: Which of the following corticosteroids would be preferred in this patient due to high anti-inflammatory potency and low sodium retention potential?

A. Cortisol
B. Fludocortisone
C. Prednisone
D. Dexamethasone
E. Triamcinolone
A

Dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Question 2: You warned the patient about the incidence of osteoporosis due to long-term use of corticosteroids. Which of the following therapeutic agents used to treat osteoporosis belongs to the class of bisphosphonates?

A. Teriparatide
B. Denosumab
C. Raloxifene
D. Zoledronic acid
E. Calcitonin
A

Zoledronic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Question 3: Which of the following side effects are least likely to be associated with long-term use of corticosteroids?

A. Induction of hyperglycemia and gluconeogenesis
B. Down regulation of anti-inflammatory mediators
C. Immunosuppression
D. Inhibition of Prostaglandin and Leukotriene synthesis
E. Stimulation of lipolysis

A

Down regulation of anti-inflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A young woman in her 41st week of gestation had been in labor for 11 hours. You noticed that the force of her uterine contractions have diminished significantly during the past hour. Which of the following substances could be used to stimulate this patient’s uterine contractions?

A. Insulin
B. Luteinizing hormone
C. Oxytocin
D. Thyroxine
E. Calcitonin
A

Oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A 39 years old patient is undergoing assisted reproductive technology (ART) to improve her chances of conceiving. Her therapeutic regimen includes a combination of luteinizing hormone (LH) and follicle stimulating hormone (FSH) extracted from the urine of menopausal women. Which of the following therapeutic agent was administered?

A. Oxandrolone
B. Liotrix
C. Danazol
D. Menotropin
E. Estrone
A

Menotropin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A 27 years old patient visits your office to request a prescription for a combined oral contraceptive (COC). She has decided to postpone starting a family due to a hectic professional career.

Question 1: Before prescribing a COC which of the following contraindications must be ruled out?

A. Hirsutism
B. Sedentary lifestyle
C. Peptic ulcer
D. Pregnancy
E. Seasonal allergies
A

Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Question 2: During your interaction she mentioned that she has been on sumatriptan nasal spray prn for almost a year for the treatment of migraines. Which of the following contraceptive would you recommend to this patient?

A. Combined estrogen/progestin
B. Combined estrogen/progestin monophasic
C. Combined estrogen/progestin biphasic
D. Combined estrogen/progestin triphasic
E. Progestin only
A

Progestin only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Question 3: You decide to educate the patient on the difference between COCs and progestin only contraceptives. Which of the following statements describes the advantage of COCs compared to progestin only contraceptives?

A. Better safety profile
B. Less weight gain
C. Lower incidence of nausea
D. Higher efficacy
E. Low risk of edema
A

Higher efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A 55 years old patient is receiving a combination of two chemotherapeutic drugs for the treatment of hormone receptor-positive breast cancer. Tamoxifen is one of the two chemotherapeutic agents. Which of the following statements best describes the mechanism of tamoxifen?

A. Acts as an agonist of estrogen receptor in breast tissue and in endometrial tissue
B. Acts as an agonist of estrogen receptor in breast tissue and as an antagonist in endometrial tissue
C. Acts as an antagonist of estrogen receptor in breast tissue and as an agonist in endometrial tissue
D. Acts as an antagonist of estrogen receptor in breast tissue and in endometrial tissue
E. Acts only as an agonist of estrogen receptor in breast tissue

A

Acts as an antagonist of estrogen receptor in breast tissue and as an agonist in endometrial tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A 20 years old woman arrives to your clinic after two weeks following a sexual assault. She requests a prescription to terminate a potential pregnancy. After discussing all ethical considerations, which of the following drugs could be prescribed combined with misoprostol to terminate a feared pregnancy?

A. Progestin
B. Estrogen/Progestin
C. Donazol
D. Mifepristone
E. Mestranol
A

Mifepristone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A 38 years old female patient, Ms Tim, visits your clinic with chief complaint of nervousness. She further explains that she also suffers from heat intolerance, palpitations, increased appetite and insomnia. In addition, she has lost at least 7 lbs in the past five weeks. You suspect hyperthyroidism and order a blood test. Which of the following laboratory results would confirm your diagnosis?

A. Low T4, High TSH, High anti-TPO
B. Low T4, High TSH
C. High T4, Low TSH
D. High T4, Low TSH, High TSI (thyroid stimulating immunoglobulins)
E. High T4, High TSH
A

High T4, Low TSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A 38 years old female patient, Ms Tim, visits your clinic with chief complaint of nervousness. She further explains that she also suffers from heat intolerance, palpitations, increased appetite and insomnia. In addition, she has lost at least 7 lbs in the past five weeks. You suspect hyperthyroidism and order a blood test. Question 2: You recommend an initial trial of an agent known to interfere with the biosynthesis of thyroid hormones by preventing the iodination and proteolytic release of thyroid hormones. Which of the following products has been recommended?

A. Methimazole
B. Thiopropyluracil
C. SSKI (saturated solution of potassium iodine)
D. Carbimazole
E. Propranolo
A

SSKI (saturated solution of potassium iodine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

A 38 years old female patient, Ms Tim, visits your clinic with chief complaint of nervousness. She further explains that she also suffers from heat intolerance, palpitations, increased appetite and insomnia. In addition, she has lost at least 7 lbs in the past five weeks. You suspect hyperthyroidism and order a blood test.Question 3: Unfortunately, the initial therapy has not been effective in this patient. You decide to switch, Ms Tim, to a more potent therapeutic agent. Following six months of treatment her blood test results show: free T4 5.0 mcg/dL (normal: 4.5 – 11.2 mcg/dL), TSH 2.8 mIU/L (normal: 0.4 – 4.0 mIU/L). She complains of palpitations and hand tremors. How would you manage these persistent symptoms?

A. Increase the dose of the drug she is currently taking
B. Switch to another antithyroid drug
C. Add another antithyroid drug
D. Add propranolol
E. Do nothing; the symptoms will probably resolve in about two months

A

Add propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

A 48 years old patient with history of hypertension, hyperlipidemia and bipolar depression visits the clinic for his regular follow-up. He is on losartan, hydrochlorothiazide, atorvastatin, cholestyramine and lithium carbonate. He complains of cold sensitivity, constipation, fatigue and weight gain. His symptoms are consistent with hypothyroidism. A blood test confirms a diagnosis of hypothyroidism. Which of the following drugs in this patient’s therapeutic regimen is the likely offending agent?

A. Losartan
B. Hydrochlorothiazide
C. Atorvastatin
D. Cholestyramine
E. Lithium carbonate
A

Lithium carbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show FPG 226 mg/dl (Normal

A

Insuline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show FPG 226 mg/dl (Normal

A

Lower than 7% (normal is 4%-6%

26
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show FPG 226 mg/dl (Normal

A

Afrezza

27
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show: FPG 226 mg/dl (Normal:

A

Detemir

28
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show: FPG 226 mg/dl (Normal:

A

Increased Cortisol

29
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show: FPG 226 mg/dl (Normal:

A

Weight gain

30
Q

A 15 years old is brought to your office. His chief complaint is a constellation of symptoms including fatigue, excessive thirst, frequent urination and significant weight loss over the past 2 months. He has no family history of diabetes and is not on any medications. His blood test results show: FPG 226 mg/dl (Normal:

A

Fingers

31
Q

A 50 years old diabetic patient visits your office for a routine check up. His laboratory results show: blood pH 7.1 (normal: 7.35 – 7.45); pO2 82 mmHg (normal: 75 - 100 mmHg); pCO2 = 29 mmHg (normal: 33 – 44 mmHg); NaHCO3 14 mEq/L (normal: 22- 28 mEq/L).

Question 1: Which of the following drug is associated with these findings?

A. Pioglitazone
B. Insulin
C. Acarbose
D. Metformin
E. Sitagliptin
A

Metformin

32
Q

Question 2: You decide to switch the patient to a sulfonylurea. Which of the following statements is the least accurate description of the mechanism of sulfonylureas?

A. Block potassium channels in beta islets
B. Block Hepatic glucose production
C. Increase the release of insulin
D. Inhibit gluconeogenesis
E. Increase insulin sensitivity
A

inhibit gluconeogenesis

33
Q

Question 3: The newly prescribed sulfonylurea has the lowest incidence of weight gain and hypoglycemia. Which of the following sulfonylureas has been prescribed?

A. Tolbutamide
B. Glyburide
C. Glipizide
D. Glimepiride
E. Gliclazide
A

Glimepiride

34
Q

A 56 years old pre-diabetic patient presents to your clinic for follow-up. She complains of abdominal cramps, diarrhea and flatulence. She has been diligently following lifestyle changes. She is also on drug therapy to help prevent the worsening of her condition. Which of the following drugs is likely to be responsible for her symptoms?

A. Sitagliptin
B. Glyburide
C. Repaglinide
D. Canagliflozin
E. Acarbose
A

k

35
Q

A 25 year old male patient, KP, has been just diagnosed with generalized tonic- clonic seizures. His physical exam shows 5’8’’ 220 lbs. He receives a prescription for a drug known to have anticonvulsant and mood-stabilizing effects. The drug will also have positive effect on his weight. Which of the following anticonvulsants has been prescribed?

A. Lamotrigine
B. Phenobarbital
C. Valproic acid
D. Topiramate
E. Zonisamide
A

Topiramate

36
Q

Which of the following statements is the least accurate description of the mechanisms of the newly prescribed drug?

A. Sodium channel blocker
B. Carbonic anhydrase inhibitor
C. Inhibits the metabolism of GABA 
D. Increases chloride ion conduction
E. Inhibits AMPA receptors
A

Inhibits the metabolism of GABA

37
Q

Which of the following drugs is the treatment of choice for generalized clonic-tonic seizures?

A. Lamotrigine
B. Phenobarbital
C. Valproic acid
D. Topiramate
E. Zonisamide
A

Valproic acid

38
Q

MT is a 9 years old 22 kg elementary school girl. She is reported by her concerned teacher for having staring spells lasting about 5 sec at least twice daily. She has no seizures and regains full alertness immediately afterwards.

Question 1: Which of the following anticonvulsants is the treatment of choice in this patient?

A. Phenytoin
B. Ethosuximide
C. Clonazepam
D. Topiramate
E. Zonisamid
A

Ethosuximide

39
Q

: Before prescribing the anticonvulsant (drug of choice identified in question 1), you discuss with TM’s mother the side effects associated with the therapeutic regimen. Which of the following side effects is least likely to be associated with the drug of choice prescribed to this patient?

A. Gingival hyperplasia
B. Drowsiness/Poor concentration
C. Stevens-Johnson Syndrome
D. Bone marrow suppression
E. Increase intraocular pressure
A

Increase intraocular pressure

40
Q

VT is a 20-year-old college student. Her concerned mother brought her to your office for consultation. For the past five days she had little sleep and has been in a heightened state of activity which she describes as “out of control.” For the most part, her behavior is characterized by grandiose ideas that often take on a mystical tone.She has experienced two previous episodes of behavior changes similar to what she is experiencing now. Both episodes alternated with periods of intense depression. When she was in the depressed state, she could not bring herself to attend classes or any campus activities; she suffered from sadness, poor appetite, irritability and difficulty concentrating. At the lowest point of the depressive side of her disorder, VT contemplated suicide. Her symptoms are consistent with bipolar depression. You prescribe lithium.

Question 1: Which of the following pairs A, B, C, D or E represent the dual action of lithium on norepinephrine transmission as shown on the figure below?

A. S1-S3
B. S2-S4
C. S5-S2
D. S3-S4
E. S1-S5
A

S3-S4

41
Q

Which of the following is a common side effect of lithium?

A. Hypokalemia
B. Hyponatremia
C. Hypomagnesemia
D. Hypocalcemia
E. Hypochloremia
A

Hyponatremia

42
Q

Mrs John is a 32 year old who is agitated, and complains of appetite loss and low mood over the past two months. During the examination she is teary, complains of inability to sleep, and loss of interest in work and leisure activities. She has been stressed and unable to function at work. The patient denies any suicidal thoughts. She is not using any medications other than a daily multivitamin. Physical examination and other investigations are normal; the diagnosis of major depression is made. You decide to initiate antidepressant therapyThe drug prescribed inhibits the uptake of serotonin and norepinephrine and acts also on muscarinic, histamine and adrenergic receptors. Which of the following drugs has been prescribed?

A. Fluoxetine
B. Imipramine
C. Citalopram
D. Duloxetine
E. Venlafaxine
A

Imipramine

43
Q

Mrs John presents to your office for follow-up after 2 months of treatment. She complains of a constellation of side effects associated with her drug therapy. You decide to switch Mrs John to phenelzine. Phenelzine belongs to the class of:

A. Selective Serotonin Reuptake Inhibitors
B. Serotonin-Norepinephrine Reuptake Inhibitors
C. Tricyclic Antidepressants
D. Monoamine Oxidase Inhibitors
E. Atypical Antidepressants

A

Monoamine Oxidase Inhibitors

44
Q

Which of the following agents could be added to Mrs John’s therapeutic regimen to enhance the effectiveness of phenelzine?

A. Buspirone
B. Methylphenidate
C. Dextroamphetamine
D. Triiodothyronine
E. Imipramine
A

Triiodothyronine

45
Q

Which of the following is the minimum required wash out time for switching from a non-MAOI to a MAOI?

A. 2 weeks
B. 3 weeks
C. 4 weeks
D. 5 weeks
E. 6 weeks
A

2 weeks

46
Q

A 29year-old female presents visits her family physician with complaint of recurrent attacks of migraine-like headache of a pulsating quality and severe intensity, with nausea, photo- and phonophobia, that resolved spontaneously within 12hours if untreated. The attacks were preceded by reversible visual symptoms that lasted for 15–30min. Onset of the symptoms occurred 5 years earlier. Her medical history, physical and neurological examination did not suggest any other secondary disorder or head trauma. She was prescribed an abortive drug, sumatriptan.Which of the following statements describes best the mechanism of sumatriptan?

A. Stimulates 5-HT1B receptor to induce constriction of cranial blood vessels and enhances trigeminal nerve transmission due to agonistic effect at 5-HT1D receptor
B. Stimulates 5-HT1B receptor to induce constriction of cranial blood vessels and inhibits the biosynthesis of prostaglandins
C. Antagonizes 5-HT1B receptor to induce constriction of cranial blood vessels and inhibits trigeminal nerve transmission due to agonistic effect at 5-HT1D receptor
D. Inhibits trigeminal nerve transmission due to agonistic effect at 5-HT1D receptor and inhibits the biosynthesis of prostaglandins
E. Stimulates 5-HT1B receptor to induce constriction of cranial blood vessels and inhibits trigeminal nerve transmission due to agonistic effect at 5-HT1D receptor

A

Stimulates 5-HT1B receptor to induce constriction of cranial blood vessels and inhibits trigeminal nerve transmission due to agonistic effect at 5-HT1D receptor

47
Q

A 38-year-old man was seen in the emergency department following a referral by his general practitioner, as there were concerns from his family that he was voicing bizarre ideas. He complained of feeling increasingly stressed, anxious and paranoid and he was having flashbacks of fictional events from his past. He had beliefs that many people from his local community were involved in a conspiracy against him and he was being provoked by other people to get into fights. He also had beliefs that he was being followed and watched. He has no family history of any mental health related problems. He had experimented with recreational drugs such as cocaine and ecstasy in the past but he denied any use of recreational drugs in the last 2 years. Considering that his symptoms are primarily positive, you prescribe a typical antipsychotic, haloperidol.
Question 1: The primary site of action of haloperidol is:

A

C

48
Q

A 38-year-old man was seen in the emergency department following a referral by his general practitioner, as there were concerns from his family that he was voicing bizarre ideas. He complained of feeling increasingly stressed, anxious and paranoid and he was having flashbacks of fictional events from his past. He had beliefs that many people from his local community were involved in a conspiracy against him and he was being provoked by other people to get into fights. He also had beliefs that he was being followed and watched. He has no family history of any mental health related problems. He had experimented with recreational drugs such as cocaine and ecstasy in the past but he denied any use of recreational drugs in the last 2 years. Considering that his symptoms are primarily positive, you prescribe a typical antipsychotic, haloperidol.
Question 1: The primary site of action of haloperidol is:: His psychotic symptoms gradually improved over the following weeks but he started experiencing extrapyramidal side effects. You decide to switch the patient to an atypical psychotic to reduce the incidence of extrapyramidal side effects. Which of the following drugs was prescribed?

A. Fluphenazine
B. Clozapine
C. Thiothixene
D. Thioridazine
E. Promethazine
A

Clozapine

49
Q

Which of the following adverse reactions is associated with the use of the newly prescribed antipsychotic?

A. Hypertension
B. Tardive Dyskinesia
C. Neuroleptic Malignant Syndrome
D. Agranulocytosis
E. None of the above
A

Agranulocytosis

50
Q

JT is a 38 years old truck driver who has been recently diagnosed with psychosis. He has a mix of positive and negative symptoms. Which of the following antipsychotics would be preferred in this patient?

A. Aripiprazole
B. Quetiapine
C. Risperidone
D. Ziprasidone
E. Olanzapine
A

Aripiprazole

51
Q

A 51 year old woman with multiple risk factors is placed on raloxifene for prophylaxis against post-menopausal osteoporosis.

Question 1: Before writing her prescription you warn her about the risks associated with many SERMs, which includes an increased risk of:

A. Breast cancer
B. Infections
C. Thromboembolic events
D. Hyperlipidemia
E. Allergic reaction
A

Thromboembolic events

52
Q

Adequate intake of vitamin D and calcium could also prevent the incidence of osteoporosis. Which of the following is the recommended daily intake of vitamin D and calcium for this patient?

A. 500 IU – 1000 mg
B. 500 IU – 1200 mg
C. 500 IU – 1500 mg
D. 600 IU – 1000 mg
E. 600 IU – 1200 mg
A

600 IU – 1200 mg

53
Q

BD, a 52-year-old female, presents to her primary care provider with complaints of weakness and fatigue, although she continued to work. She attributes these changes to menopause; her menstrual periods have been irregular but occasionally heavy. She has also lost about 10 lbs over the past 6 months not attributable to diet or exercise. In addition, the patient reported chronic constipation and hemorrhoids. Her blood test reveals low hematocrit of 26%. After additional testing, her anemia is attributed to blood loss. BD was referred to the Gastroenterology Department. A mass approximately 6 cm in size located in the ascending colon was found by colonoscopy. Colon cancer was confirmed by biopsy. Targeted drug therapy was initiated with an antiangiogenic agent. Which of the following drugs was prescribed?

A. Gemtuzumab 
B. Bevacizumab 
C. Rituximab
D. Trastuzumab
E. Cetuximab
A

Bevacizumab

54
Q

A 45 year old woman with Hodgkin’s disease was treated with a combination of the following chemothepapeutic drugs: cisplatin, doxorubicin, bleomycin, vinblastine and dacarbazine. Three years later she develops cardiomyopathy, followed by congestive heart failure (CHF). Which of the following drugs in her therapeutic regimen is most likely responsible for her heart failure?

A. Cisplatin
B. Doxorubicin 
C. Bleomycin 
D. Dacarbazine 
E. Vinblastine
A

Doxorubicin

55
Q

50 year old woman with metastatic breast cancer that overexpresses the HER2/neu protein is scheduled for a first cycle of combination therapy.
Question 1: Which of the following chemotherapeutic drug combinations would be more appropriate?

A. Cyclophosphamide- Doxorubicin
B Cytarabine – Fludarabine
C. Sunitinib – Tipifarnib
D. 5-Fluorouracil – Capecitabine
E. Etoposide - Teniposide
A

Sunitinib – Tipifarnib

56
Q

50 year old woman with metastatic breast cancer that overexpresses the HER2/neu protein is scheduled for a first cycle of combination therapy.
Which of the following targeted therapies could be added to the previous drug combination to enhance the effectiveness of this patient’s chemotherapy?

A. Gemtuzumab 
B. Bevacizumab 
C. Rituximab
D. Trastuzumab
E. Cetuximab
A

Trastuzumab

57
Q

A 25-year-old gentleman with a history of schizophrenia has recently been started on haloperidol deaconate. Which of the following could be a reason for starting this form of medication?

  1. Patient recently experienced the onset of tardive dyskinesia
  2. Concern for the risk of neuroleptic malignant syndrome
  3. Patient requires a more potent form of an atypical antipsychotic
  4. To lower the risk of extrapyramidal symptoms
  5. Patient has a history of noncompliance with his antipsychotic medications
A

Patient has a history of noncompliance with his antipsychotic medications

58
Q
A 33-year-old woman with a history of Graves’ disease is brought to the emergency department unresponsive following a bout of confusion and agitation. On physical examination her temperature is 39.2Åã C (102.5Åã F), her blood pressure is 100/70 mm Hg, and her pulse is 165/min. A systolic ejection murmur is heard at the apex, and the patient has 3+ pitting edema at the ankles. Following primary stabilization, which of the following would constitute appropriate pharmacotherapy for this patient’s underlying condition?
(A) Aspirin
(B) Dobutamine
(C) Iodine
(D) Levothyroxine
(E) Propylthiouracil
A

Propylthiouracil

59
Q
A 32-year-old woman presents to her primary care physician complaining of overwhelming fear and apprehension. The patient states that for the past 8 months she has been feeling anxious and worried about many things. She has difficulty concentrating and difficulty sleeping because she “can’t seem to keep [her] mind off of the everyday issues of life.” She also says she often feels tense and restless. She denies past substance abuse. Which of the following drugs would be considered fIrst-line treatment for her illness?
(A) Amitriptyline
(B) Buspirone
(C) Diazepam
(D) Flumazenil
(E) Midazolam
A

Diazepam

60
Q
Genetic analysis of a female infant with a broad, enlarged neck demonstrates an XO karyotype. When the child reaches puberty, hormone replacement therapy should be started with which of the following agents?
(A) Estrogen only
(B) Estrogen and progestin
(C) Insulin
(D) Progestin only
(E) Thyroid hormone
A

Estrogen and progestin